December 2025 in “International Journal of Innovative Technologies in Social Science” This review outlines that minoxidil (topical and oral) and 5α-reductase inhibitors are the most effective treatments for androgenetic alopecia, with additional therapies like platelet-rich plasma and hair transplantation enhancing results, emphasizing the need for individualized, combination approaches.
December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology” This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
December 2025 in “International Journal of Innovative Technologies in Social Science” This review identified emerging therapies for androgenetic alopecia, such as low-dose oral minoxidil and stem cell-based treatments, which show promise for improved hair loss management but require standardized protocols and large-scale trials for further validation.
December 2025 in “Progress in Biomedical Engineering” This article reviews emerging mechanobiological strategies like electrical stimulation and microneedling combined with nanotechnology as non-invasive methods for hair loss treatment, suggesting these approaches could provide futuristic alternatives to current therapies such as minoxidil, finasteride, and hair transplants.
December 2025 in “Medicine - Programa de Formación Médica Continuada Acreditado” This review synthesizes recent advancements in clinical trichology, highlighting updates on androgenetic alopecia treatments like low-dose oral minoxidil, 5α-reductase inhibitors, and other therapeutic options for various alopecia types, including telogen/anagen effluvium and alopecia areata, and detailed approaches for scarring alopecias and pediatric trichology.
This article discusses the role of women’s health nurse practitioners in diagnosing and managing female hair loss, particularly highlighting the treatment options for female pattern hair loss, which affects up to 50% of women over 50.
This review discusses various Complementary and Alternative Medicine methods for hair care, such as herbal remedies and hair regeneration techniques, but reports no new clinical findings.
This review highlights that recent advancements in diagnostics and therapies, including AI-enhanced imaging, biomarker analysis, and novel treatments like low-dose oral minoxidil and JAK inhibitors, are improving the precision and customization of hair loss management.
This study reviewed contemporary literature and found that combining minoxidil with topical finasteride, biologic adjuvants, or delivery innovations might enhance treatment effectiveness for androgenetic alopecia compared to minoxidil alone, although diverse outcomes and incomplete data limit broader conclusions.
Hair loss can be managed with medications, therapies, and lifestyle changes to prevent loss and encourage growth.
Certain combination therapies, like microneedling with minoxidil, are more effective for female-pattern hair loss than other treatments.
September 2024 in “Ain Shams Medical Journal” This review discusses the prevalence, pathogenesis, and treatments of androgenic alopecia but reports no new research findings; the authors emphasize the need for further exploration of novel treatment options.
August 2024 in “Dermatological Reviews” This review discusses how emerging technologies in dermatology are enhancing the ability to diagnose and treat hair and nail disorders more accurately and effectively, highlighting advancements in both diagnostic techniques and therapeutic methods such as AI-driven technologies that personalize patient care and improve outcomes.
May 2024 in “Journal of cosmetic and laser therapy” This systematic review concluded that various treatments, such as topical minoxidil, oral finasteride, and hair transplantation, effectively promote hair growth in androgenic alopecia, emphasizing the benefits of a personalized, multifaceted treatment approach.
May 2024 in “International Society of Hair Restoration Surgery” This paper describes various emerging regenerative therapies for hair loss, such as platelet-rich plasma, exosomes, and low-level laser therapy, but it doesn't provide results or conclusions about their efficacy.
February 2024 in “Actas Dermo-Sifiliográficas” This study involved a Delphi-method consensus from 34 Spanish dermatologists, outlining structured recommendations for managing androgenetic alopecia based on available scientific evidence and expert opinions, aiming to guide clinical practice amid limited treatment approvals and varying effectiveness.
December 2023 in “Farmateka” Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.
November 2023 in “Journal of Student Research” This review article evaluates new treatment techniques for androgenetic alopecia, including low-level laser therapy, platelet-rich plasma therapy, microneedling, and topical growth factors and peptides, reporting positive outcomes such as hair regrowth and improved hair density and thickness.
October 2023 in “Facial Plastic Surgery” This study discusses current treatments for androgenetic alopecia like minoxidil and finasteride and highlights emerging therapies including regenerative medicine and low-level laser therapy due to some patients not responding well to standard options.
August 2023 in “Journal of The American Academy of Dermatology” This source highlights new developments in treating androgenetic alopecia, including low-dose oral minoxidil and advancements in photobiomodulation, platelet-rich plasma, and hair transplantation techniques, providing clinicians with more options.
June 2023 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This review discusses various therapies for androgenetic alopecia, highlighting minoxidil, finasteride, and PRP as effective and widely accessible options, but reports no new clinical results.
June 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This article reviews existing and emerging treatment methods for androgenetic alopecia non-surgically, suggesting some could potentially reverse disease progression, but notes each approach still faces certain limitations.
May 2023 in “Elsevier eBooks” This study reviews treatments for scarring alopecia, highlighting that the primary approach focuses on reducing inflammation and preventing progression, with corticosteroids as a common initial treatment.
May 2023 in “Clinics in Plastic Surgery” This study suggests that platelet-rich plasma injections are a promising option for the treatment of androgenetic alopecia, both alone and as an addition to other nonsurgical and surgical treatments.
April 2023 in “Journal of Cutaneous and Aesthetic Surgery” This review proposes a combination treatment scheme with a rotational approach for managing androgenetic alopecia, drawing on evidence for effectiveness, long-term use convenience, and patient acceptance, but presents no new clinical results.
April 2022 in “Medicina estética” This review of female androgenetic alopecia treatments reports limited therapeutic options due to unclear pathogenesis, with minoxidil as the only FDA-approved treatment and adjuvant therapies under investigation.
This extended abstract discusses various treatments for alopecia, including low-level light therapy, which has shown promise but requires further research to establish effectiveness, especially in combination with other therapies.
October 2018 in “InTech eBooks” This article reviews various treatments for alopecia, highlighting that minoxidil, finasteride, PRP therapy, and hair transplants are the most commonly used options, but it reports no new clinical results.
January 2016 in “Georg Thieme Verlag eBooks” The document recommends personalized, culturally sensitive treatments to rejuvenate the aging Asian face, focusing on natural results and specific techniques for skin, hair, and facial features.
This article discusses various treatments for androgenic alopecia, focusing on subcutaneous injections of autologous platelet-rich plasma, but does not report new clinical results.